ArticleOncotarget2018

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma.

De-Xiu Bu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.